Slow stomach emptying after pancreatic surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This retrospective project collects clinical, laboratory, and imaging data from adults who underwent pancreatic surgery at National Taiwan University Hospital. Investigators will gather preoperative and postoperative blood tests (blood counts, biochemistry, tumor markers, glucose- and lipid-related tests) and imaging studies (CT, MRI, ultrasound, PET, endoscopy) along with surgical details. They will compare surgical methods, gastrointestinal feeding tube placement, lesion margin clearance rates, and postoperative remnant pancreatic volume to the occurrence of delayed gastric emptying and related quality-of-life measures. The goal is to identify risk factors that predict delayed gastric emptying and to inform perioperative management.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Males or females aged 20 years or older.
2. Patients scheduled to undergo pancreatic surgery.

Exclusion Criteria:

1. Patients under 20 years of age at this hospital.
2. Presence of other active malignancies prior to diagnosis.
3. Minors, pregnant women, breastfeeding women, and patients with psychiatric disorders.

Where it's running

• National Taiwan University Hospital
  Taipei, Taiwn, Taiwan Recruiting

Study contacts

• Study coordinator: Yu Wen Tien, Ph.D.
• Email: ywtien5106@ntu.edu.tw
• Phone: 0972651427

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How hormone and digestion functions and outcomes change after pancreas surgery

  This project will look back at medical records to see if different pancreatectomy methods, margin clearance, and how much pancreas is left affect hormone (endocrine) and digestion (exocrine) function and overall outcomes in adults who had pancreas surgery at our hospital.

  Recruiting National Taiwan University Hospital · Taipei, Taiwan · NCT07396662

• Carbon ion radiotherapy for frail people with pancreatic cancer

  This trial will try carbon ion radiotherapy as a treatment for people with non-metastatic pancreatic cancer who are too frail for surgery or standard chemotherapy.

  Recruiting Phase 2 Yonsei University · Seoul · NCT07257523

• Using ctDNA methylation to guide prognosis and monitoring in pancreatic cancer

  This project tests whether a blood test that measures ctDNA methylation can help detect and monitor pancreatic cancer in adults who are undergoing surgery or biopsy.

  Recruiting Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT07045571

• Lanreotide versus placebo before surgery to prevent a pancreatic fistula

  This trial will see if giving lanreotide before a planned distal pancreatectomy lowers the risk of a pancreatic fistula in adults with pancreatic cancer or a suspicious pancreatic lesion.

  Recruiting at 18 sites Phase 3 SWOG Cancer Research Network · Birmingham, Alabama and 117 other locations · NCT06807437

• Using MRI to Diagnose Pancreatic Masses

  This study is testing if a special MRI technique can help doctors better understand pancreatic cancer by measuring the stiffness of tumors to improve treatment decisions for patients.

  Recruiting Shengjing Hospital · Shenyang, Liaoning · NCT06526442

• Comparing two pain relief methods after pancreas surgery

  This study is testing whether a new way of giving pain relief after pancreas surgery works just as well as the traditional method, to help patients feel better with fewer risks.

  Recruiting Phase 2 Masonic Cancer Center, University of Minnesota · Minneapolis, Minnesota · NCT06411795

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.